The Latest Moves of 2 Top Hedge Funds and One Bullish Pick You Might Want to Follow

Page 2 of 2

Having gained experience in the risk arbitrage divisions of Bass Brothers and Maxxam Group, Clint Carlson started Carlson Capital in 1993, employing a multi-strategy approach to investing. He has used a mix of fundamental analysis and different types of arbitrage strategies to develop an equity portfolio with an estimated value of $9.1 billion at the end of June. Carlson’s investments are well diversified among a large number of sectors, with technology and financial stocks among his favorites. According to its latest 13F filing, Carlson Capital’s largest equity position is Citigroup Inc (NYSE:C), with Carlson having increased his stake by 49% to 5.03 million shares. He has also nearly doubled his investments in Exelon Corporation (NYSE:EXC), a provider of utility services, and Partnerre Ltd (NYSE:PRE), an insurance holding company. Carlson Capital holds 8.37 million shares of Exelon and 1.24 million shares of Partnerre.

Follow Clint Carlson's Carlson Capital

Ultratech, Inc. (NASDAQ:UTEK)‘s stock has been on a “montagne-russe” ride so far this year and is currently 16.3% in the red, dancing around the $15.8 level. For the quarter ending July 4, the company posted revenues of $45.9 million, up by 24.6% year-over-year and has returned to profitability with earnings of $0.06 per share. Wall Street does not expect the good times to last, estimating a loss of $0.15 per share and revenues of $35.6 million for the current quarter.

Follow Ultratech Inc (NASDAQ:UTEK)

Phill Gross and Robert Atchinson are also betting on Ultratech, having increased their stake by 10% during the second quarter to 703,726 shares, while D. E. Shaw holds a similar position of 736,405 shares, up by 25% during the quarter. While the number of hedge funds with long positions in Ultratech, Inc. (NASDAQ:UTEK) decreased to 11 from 13 between April and June, the overall value of their holdings has risen by 19.6% to $113 million and account for approximately 22.1% of the total outstanding stock.

Disclosure: none.

Page 2 of 2